Abstract
Fibrosis represents the common end stage of chronic organ injury independent of the initial insult, destroying tissue architecture and driving organ failure. Here we discover a population of profibrotic macrophages marked by expression of Spp1, Fn1, and Arg1 (termed Spp1 macrophages), which expands after organ injury. Using an unbiased approach, we identify the chemokine (C-X-C motif) ligand 4 (CXCL4) to be among the top upregulated genes during profibrotic Spp1 macrophage differentiation. In vitro and in vivo studies show that loss of Cxcl4 abrogates profibrotic Spp1 macrophage differentiation and ameliorates fibrosis after both heart and kidney injury. Moreover, we find that platelets, the most abundant source of CXCL4 in vivo, drive profibrotic Spp1 macrophage differentiation. Single nuclear RNA sequencing with ligand-receptor interaction analysis reveals that macrophages orchestrate fibroblast activation via Spp1, Fn1, and Sema3 crosstalk. Finally, we confirm that Spp1 macrophages expand in both human chronic kidney disease and heart failure.
Original language | English |
---|---|
Article number | 112131 |
Journal | Cell Reports |
Volume | 42 |
Issue number | 2 |
DOIs | |
Publication status | Published - 28 Feb 2023 |
Bibliographical note
Funding Information:This work was supported by RWTH Aachen University Clinician Scientist grants to K.H. and D.S. as well as an RWTH Aachen University START grant (139/21) to K.H. G.S. received funding from the German Society of Internal Medicine (DGIM, Peter-Scriba MD grant) and German Society for Cardiology (DGK, Otto-Hess MD grant). A.W. was funded by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement No. GA 884754). This work was mainly funded by grants of the German Research Foundation (DFG: SFBTRR219 322900939, CRU344-4288578857858, CRU5011-445703531), by grants of the European Research Council (ERC-StG 677448 and ERC-CoG 101043403), the ERA-CVD MENDAGE consortium (BMBF 01KL1907), and the NWO VIDI 09150172010072 (all to R.K.). R.K. and R.K.S. received support of the BMBF Consortia FibroMap and CureFib. R.K.S. further received funding from ERC Starting grant deFIBER; ERC-StG 757339. P.B. is supported by the German Research Foundation (DFG, Project IDs: 322900939, 454024652, 432698239, and 445703531, the latter also to B.M.K.), the European Research Council (ERC, Consolidator Grant No 101001791). Individual images for the design of experimental timelines were taken from the Smart servier medical art server (https://smart.servier.com). The graphical abstract was created using biorender. K.H. G.S. and R.K. designed the study and interpreted the data. K.H. H.K. and S.H. designed the data analysis plan. K.H. G.S. and R.K. wrote the manuscript and organized the figures. R.K.S. A.W. I.C. and S.H. provided conceptual support, advised on data interpretation, and edited the manuscript. D.S. G.S. K.H. and E.L. performed myocardial infarction surgeries and mice echocardiography. G.S. performed echocardiographic data analysis. K.H. and G.S. performed all other mouse experiments with assistance from S.M. S.Z. established the Gli1+ fibroblast cell line. G.S. and K.H. performed all other cell culture experiments with assistance from Q.L. and L.K. G.S. B.M.K. and P.B. performed staining, imaging, and quantification of picrosirius red stains. G.S. performed ISH and IF stainings and data analysis with assistance from Q.L. L.K. and M.H. K.H. G.S. and F.P. performed single nuclei isolation and single nuclear RNA library preparation. K.H. H.K. S.H. and G.S. carried out single-cell and high-throughput data analysis. T.B. performed Symphony Reference Mapping Analysis with assistance from J.N. C.K. and J.K. collected patient nephrectomy tissues. C.K. performed TMA embedding. K.H. and R.K. initiated the study. All authors read and approved the final manuscript. The authors declare no competing interests.
Funding Information:
This work was supported by RWTH Aachen University Clinician Scientist grants to K.H. and D.S., as well as an RWTH Aachen University START grant ( 139/21 ) to K.H. G.S. received funding from the German Society of Internal Medicine (DGIM, Peter-Scriba MD grant) and German Society for Cardiology (DGK, Otto-Hess MD grant). A.W. was funded by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement No. GA 884754 ). This work was mainly funded by grants of the German Research Foundation (DFG: SFBTRR219 322900939 , CRU344-4288578857858, CRU5011-445703531 ), by grants of the European Research Council ( ERC-StG 677448 and ERC-CoG 101043403 ), the ERA-CVD MENDAGE consortium ( BMBF 01KL1907 ), and the NWO VIDI 09150172010072 (all to R.K.). R.K. and R.K.S. received support of the BMBF Consortia FibroMap and CureFib. R.K.S. further received funding from ERC Starting grant deFIBER; ERC-StG 757339 . P.B. is supported by the German Research Foundation (DFG, Project IDs: 322900939 , 454024652 , 432698239 , and 445703531 , the latter also to B.M.K.), the European Research Council (ERC, Consolidator Grant No 101001791 ). Individual images for the design of experimental timelines were taken from the Smart servier medical art server ( https://smart.servier.com ). The graphical abstract was created using biorender.
Publisher Copyright:
© 2023 The Author(s)